During the past decade, Brigham and Women's Hospital - Infectious Diseases conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brigham and Women's Hospital - Infectious Diseases" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Glaxo Wellcome" with 2 trials as a collaborator, "Biocine" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Brigham and Women's Hospital - Infectious Diseases" are "HIV Infections" (6 trials), "COVID-19" (4 trials), "Pregnancy" (2 trials), "Cytomegalovirus Infection" (1 trials) and "HIV Seronegativity" (1 trials). Many other conditions were trialed in "Brigham and Women's Hospital - Infectious Diseases" in a lesser frequency.

Most popular intervention types in "Brigham and Women's Hospital - Infectious Diseases" are "Drug" (11 trials), "Biological" (7 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Remdesivir" (3 trials), "Zidovudine" (3 trials), "Zalcitabine" (2 trials) and "AS03" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brigham and Women's Hospital - Infectious Diseases" are 12 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Brigham and Women's Hospital - Infectious Diseases". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Brigham and Women's Hospital - Infectious Diseases, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Brigham and Women's Hospital - Infectious Diseases, 4 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".